ArticlePloS one2017

Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile.

Zhengjia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.